| Filed On | Filing |
|---|---|
| 12 Aug 2026 |
Form 4: Sanofi, 10% owner
Received 672,778 shares by conversion |
| 12 Aug 2026 |
Form 4: 5AM Ventures VI, L.p., 10% owner and 5 others
Received 7,325,962 shares by conversion |
| 11 Aug 2026 |
Form 4: Westlake BioPartners Fund I, L.p., 10% owner and 5 others
Received 12,695,305 shares by conversion |
| 10 Aug 2026 |
Form 4: Foresite Capital Management V, Llc, 10% owner and 5 others
Received 9,041,328 shares by conversion · Bought 140,000 shares ($2.52M) |
| 10 Aug 2026 |
Form 4: Tananbaum James B., Director
Received 9,041,328 shares by conversion · Bought 140,000 shares ($2.52M) |
| 10 Aug 2026 |
Form 4: Smith Todd N, Director
Granted 105,542 Director Stock Option (right to buy) |
| 10 Aug 2026 |
Form 4: Seidenberg Beth C, Director
Received 12,695,305 shares by conversion |
Loading...